Countries’ economy, healthcare system linked to cholesterol rates
- Countries with higher national income levels, lower out-of-pocket healthcare costs, and high performing and efficient health systems tend to have lower rates of high cholesterol among people with a history of high cholesterol.
- Strategies to prevent and manage cardiovascular disease should consider many factors, including how countries’ healthcare systems and economies may affect optimal care.
EMBARGOED UNTIL 3 pm CT/4 pm ET, Monday, April 9
DALLAS, April 9, 2012 — People with a history of high cholesterol who come from higher income countries or countries with lower out-of-pocket healthcare expenses, as well as those from countries with high performing healthcare systems, defined using World Health Organization (WHO) indices, tend to have lower subsequent cholesterol rates, according to new research in the American Heart Association journal Circulation.
“We found that patients living in countries in the highest third of gross national income or WHO health system achievement and performance/efficiency indices had a significantly lower likelihood of having elevated total cholesterol levels than patients from countries falling in the lower two-thirds,” said Elizabeth A. Magnuson, Sc.D., lead author of the study and director of the Health Economics and Technology Assessment at Saint Luke’s Mid America Heart Institute in Kansas City, Mo. “Patients from countries falling within the highest third of all countries studied for out-of-pocket health expenditures were more likely to have elevated total cholesterol than patients who had lower out-of-pocket costs.”
Researchers studied a database of more than 53,000 patients at elevated risk of heart attack or stroke from 36 countries in North and Latin America, Western and Eastern Europe, the Middle East, Asia, Japan and Australia.
They focused on the proportion of patients with total cholesterol of more than 200 mg/dL and how it might be associated with several factors including a country’s gross national income, how well the health system functions, and the proportion of healthcare expenses that are paid for out-of-pocket. They found:
- Among the 38 percent of patients with high total cholesterol levels, rates varied widely across countries, ranging from 73 percent in Bulgaria to 24 percent in Finland.
- Patients with a prior history of high cholesterol had higher rates than those newly diagnosed.
- Elevated cholesterol rates were particularly high among patients in Eastern European countries: Bulgaria, Lithuania, Romania, Ukraine, Hungary and Russia. These countries also ranked relatively low on health system and economic indicators.
- While the United States had rates of elevated cholesterol similar to other developed countries -- such as Finland, the U.K., Israel, Australia and Canada -- levels of healthcare spending was considerably higher than in other developed countries.
- For patients with a history of high cholesterol, country-specific rates of high total cholesterol tended to increase as country-level income and health system performance decreased.
For patients without a prior history of high cholesterol, the researchers found no associations between country-level economy and health system factors and the likelihood of elevated cholesterol.
“Optimal management of cardiovascular disease is complex, and country-level variation in rates of elevated cholesterol may be due to differences in clinical guidelines, as well as whether and the extent to which guidelines are followed and specific initiatives are effectively implemented,” Magnuson said. “The association between high cholesterol and out-of-pocket healthcare expenses may reflect an inability or unwillingness for patients in countries with higher out-of-pocket expenses to be compliant with prescribed medications. The recent availability of generic cholesterol-lowering therapy should make out-of-pocket expense less of a barrier.”
For the study, researchers examined associations only; future studies should explore causal mechanisms or why these associations occur, Magnuson said. Furthermore, this study focused on patients with access to health care, and country-specific rates of high cholesterol may therefore be underestimated.
Co-authors are: Lakshmi Venkitachalam, Ph.D.; Kaijun Wang, Ph.D.; Avi Porath, M.D.; Ramon Corbalan, M.D.; Alan T. Hirsch, M.D; David J. Cohen, M.D., M.Sc.; Sidney C. Smith Jr., M.D.; E. Magnus Ohman, M.D.; Gabriel Steg, M.D.; and Deepak L. Bhatt, M.D., M.P.H.
Author disclosures and sources of funding are on the manuscript.
Statements and conclusions of study authors published in American Heart Association scientific journals are solely those of the study authors and do not necessarily reflect the association’s policy or position. The association makes no representation or guarantee as to their accuracy or reliability. The association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific association programs and events. The association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and device corporations are available at www.americanheart.org/corporatefunding.
Additional resources, including multimedia, are available in the right column.
For Media inquiries: (214) 706-1173
Carrie Thacker: (214) 706-1665; Carrie.Thacker@heart.org
Karen Astle: (214) 706-1392; Karen.Astle@heart.org
Julie Del Barto (broadcast): (214) 706-1330; Julie.Del.Barto@heart.org
For Public Inquiries: (800) AHA-USA1 (242-8721)